Search Results

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.

• Authors : Demchuk AM; Yue P ...

Subjects: Hemostasis* ; Intracranial Hemorrhages*/Intracranial Hemorrhages*/Intracranial Hemorrhages*/blood ; Intracranial Hemorrhages*/Intracranial Hemorrhages*/Intracranial Hemorrhages*/drug therapy

• Source: Stroke [Stroke] 2021 Jun; Vol. 52 (6), pp. 2096-2105. Date of Electronic Publication: 2021 May 10.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0235266 Publication Model: Print-Electronic Cited Medium:

Record details

A rapid pro-hemostatic approach to overcome direct oral anticoagulants.

• Authors : Thalji NK; Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, USA.; Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Subjects: Antidotes/Antidotes/Antidotes/*pharmacology ; Blood Coagulation/Blood Coagulation/Blood Coagulation/*drug effects ; Factor Xa/Factor Xa/Factor Xa/*pharmacology

• Source: Nature medicine [Nat Med] 2016 Aug; Vol. 22 (8), pp. 924-32. Date of Electronic Publication: 2016 Jul 25.Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.

• Authors : Wong PC; Department of Thrombosis Research, Bristol-Myers Squibb Company, 311 Pennington-Rocky Hill Road, Pennington, NJ 08534, USA. ; Crain EJ

Subjects: Hemostasis*; Aspirin/Aspirin/Aspirin/*therapeutic use ; Factor Xa/Factor Xa/Factor Xa/*pharmacology

• Source: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2007 Aug; Vol. 24 (1), pp. 43-51. Date of Electronic Publication: 2007 Feb 24.Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Print

Record details

Normalization of the haemostatic plugs of dogs with haemophilia A (factor VIII deficiency) following the infusion of a combination of factor Xa and phosphatidylcholine/phosphatidylserine vesicles.

• Authors : Hong yu Ni; Department of Pathology, Queen's University, Kingston, Ontario, Canada.; Giles AR

Subjects: Factor Xa/Factor Xa/Factor Xa/*administration & dosage ; Hemophilia A/Hemophilia A/Hemophilia A/*drug therapy ; Hemostasis/Hemostasis/Hemostasis/*drug effects

• Source: Thrombosis and haemostasis [Thromb Haemost] 1992 Feb 03; Vol. 67 (2), pp. 264-71.Publisher: Thieme Country of Publication: Germany NLM ID: 7608063 Publication Model: Print Cited Medium: Print ISSN: 0340-6245 (Print) Linking

Record details

Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model.

• Authors : Hilden I; Biopharmaceuticals Research Unit, Novo Nordisk, Maaloev, Denmark. ; Lauritzen B

Subjects: Models, Molecular*; Antibodies, Blocking/Antibodies, Blocking/Antibodies, Blocking/*pharmacology ; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*pharmacology

• Source: Blood [Blood] 2012 Jun 14; Vol. 119 (24), pp. 5871-8. Date of Electronic Publication: 2012 May 04.Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Invertebrate compounds acting on the hemostatic mechanism.

• Authors : Arocha-Piñango CL; Centro de Medicina Experimental, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela. ; Marchi R

Subjects: Factor Xa*; Biological Factors/Biological Factors/Biological Factors/*pharmacology ; Hematologic Agents/Hematologic Agents/Hematologic Agents/*pharmacology

• Source: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 1999 Mar; Vol. 10 (2), pp. 43-68.Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9102551 Publication Model: Print Cited Medium: Print ISSN:

Record details

Agricola

Record details

Evaluation of the changes in hemostatic parameters induced by etoricoxib in rat model.

• Authors : Dalmora SL; Department of Industrial Pharmacy, Federal University of Santa Maria, Santa Maria-RS, Brazil. ; Sangoi MS

Subjects: Cyclooxygenase Inhibitors/Cyclooxygenase Inhibitors/Cyclooxygenase Inhibitors/*pharmacology ; Factor Xa/Factor Xa/Factor Xa/*drug effects ; Hemostasis/Hemostasis/Hemostasis/*drug effects

• Source: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2008 Apr; Vol. 19 (3), pp. 254-7.Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9102551 Publication Model: Print Cited Medium: Print ISSN:

Record details

Proteolytic cleavage of protein S during the hemostatic response.

• Authors : Brinkman HJ; Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands. ; Mertens K

Subjects: Hemostasis*; Factor Xa/Factor Xa/Factor Xa/*metabolism ; Protein S/Protein S/Protein S/*metabolism

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2005 Dec; Vol. 3 (12), pp. 2712-20.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print Cited Medium: Print ISSN: 1538-7933 (Print)

Record details

The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.

• Authors : Hoffman M; Monroe DM 3rd

Subjects: Factor VII/Factor VII/Factor VII/*pharmacology ; Factor Xa/Factor Xa/Factor Xa/*drug effects ; Hemostasis/Hemostasis/Hemostasis/*drug effects

• Source: Disease-a-month : DM [Dis Mon] 2003 Jan; Vol. 49 (1), pp. 14-21.Publisher: Mosby Country of Publication: United States NLM ID: 0370657 Publication Model: Print Cited Medium: Print ISSN: 0011-5029 (Print)

Record details